Search Results - "Mahowald, Maren L."

Refine Results
  1. 1

    Intraarticular Botulinum Toxin A for Refractory Painful Total Knee Arthroplasty: A Randomized Controlled Trial by SINGH, Jasvinder A, MAHOWALD, Maren L, NOORBALOOCHI, Siamak

    Published in Journal of rheumatology (01-11-2010)
    “…To assess short-term efficacy of single intraarticular botulinum toxin (IA-BoNT/A) injection in patients with chronically painful total knee arthroplasty (TKA)…”
    Get full text
    Journal Article
  2. 2

    Pain Behavior Measures to Quantitate Joint Pain and Response to Neurotoxin Treatment in Murine Models of Arthritis by Krug, Hollis E., Frizelle, Sandra, McGarraugh, Pari, Mahowald, Maren L.

    Published in Pain medicine (Malden, Mass.) (01-10-2009)
    “…ABSTRACT Objective.  To evaluate the validity of newly developed pain behavior measures in two murine models of inflammatory arthritis and to determine the…”
    Get full text
    Journal Article
  3. 3

    Development and Evaluation of an Integrated Musculoskeletal Disease Course for Medical Students by Saleh, Khaled, Messner, Ronald, Axtell, Sara, Harris, Ilene, Mahowald, Maren L

    “…BACKGROUND:A recent survey of medical and surgical residents in the United States suggested that our current training of physicians may be inadequate to meet…”
    Get full text
    Journal Article
  4. 4

    The analgesic effect of intraarticular OnabotulinumtoxinA in a female murine model of collagenase induced chronic degenerative monoarthritis by Blanshan, Nicole, Mahowald, Maren L., Dorman, Christopher, Frizelle, Sandra, Krug, Hollis E.

    Published in Toxicon (Oxford) (01-02-2019)
    “…We previously reported the efficacy of intraarticular (IA) rimabotulinumtoxinB (BoNT/B) in a murine model of chronic degenerative arthritis pain. This study…”
    Get full text
    Journal Article
  5. 5

    Intra-articular botulinum toxin A for refractory shoulder pain: a randomized, double-blinded, placebo-controlled trial by Singh, Jasvinder A, Mahowald, Maren L, Noorbaloochi, Siamak

    “…We compared the short-term efficacy and safety of intra-articular (IA) botulinum toxin A (BoNT/A) to IA-placebo in patients with chronic, refractory shoulder…”
    Get full text
    Journal Article
  6. 6

    A comparison of DigiGait™ and TreadScan™ imaging systems: assessment of pain using gait analysis in murine monoarthritis by Dorman, Christopher W, Krug, Hollis E, Frizelle, Sandra P, Funkenbusch, Sonia, Mahowald, Maren L

    Published in Journal of pain research (01-01-2014)
    “…Carrageenan-induced arthritis is a painful acute arthritis model that is simple to induce, with peak pain and inflammation occurring at about 3 hours. This…”
    Get full text
    Journal Article
  7. 7

    Long term effects of intra-articular botulinum toxin A for refractory joint pain by Mahowald, M L, Singh, J A, Dykstra, D

    Published in Neurotoxicity research (01-04-2006)
    “…The purpose of this case series review is to describe our 12 month clinical experience with intra-articular injections of Botulinum toxin Type A (BoNT/A) for…”
    Get full text
    Journal Article
  8. 8

    The effect of intra-articular vanilloid receptor agonists on pain behavior measures in a murine model of acute monoarthritis by Abdullah, Mishal, Mahowald, Maren L, Frizelle, Sandra P, Dorman, Christopher W, Funkenbusch, Sonia C, Krug, Hollis E

    Published in Journal of pain research (01-01-2016)
    “…Arthritis is the most common cause of disability in the US, and the primary manifestation of arthritis is joint pain that leads to progressive physical…”
    Get full text
    Journal Article
  9. 9

    Intra-articular botulinum toxin A as an adjunctive therapy for refractory joint pain in patients with rheumatoid arthritis receiving biologics: A report of two cases by Singh, Jasvinder A, Mahowald, Maren L

    Published in Joint, bone, spine : revue du rhumatisme (01-03-2009)
    “…Abstract We report the use of intra-articular Botulinum toxin A in two RA patients with persistently painful monoarthritis in ankle/feet joints. Both patients…”
    Get full text
    Journal Article
  10. 10

    Mactinin: a modulator of the monocyte response to inflammation by Luikart, Sharon D, Krug, Hollis E, Nelson, Robert D, Hinkel, Timothy, Majeski, Peter, Gupta, Pankaj, Mahowald, Maren L, Oegema, Theodore

    Published in Arthritis research & therapy (01-01-2003)
    “…During inflammatory processes, monocytes leave the blood stream at increased rates and enter inflammation tissue, where they undergo phenotypic transformation…”
    Get full text
    Journal Article
  11. 11
  12. 12

    Opioid use by patients in an orthopedics spine clinic by Mahowald, Maren L., Singh, Jasvinder A., Majeski, Peter

    Published in Arthritis and rheumatism (01-01-2005)
    “…Objective Concerns regarding the efficacy, toxicity, tolerance, dependence, and abuse of opioids have limited their use for patients with chronic spine pain…”
    Get full text
    Journal Article
  13. 13

    Medical residents' beliefs and concerns about using opioids to treat chronic cancer and noncancer pain: a pilot study by Roth, Craig S, Burgess, Diana J, Mahowald, Maren L

    “…This study assessed and compared residents' beliefs and concerns about using opioids for treating pain in patients with cancer and noncancer low back pain…”
    Get full text
    Journal Article
  14. 14
  15. 15

    Life-threatening reaction to vancomycin given for noninfectious fever by Johnson, , JR, Burke, MS, Mahowald, ML, Ytterberg, SR

    Published in The Annals of pharmacotherapy (01-10-1999)
    “…OBJECTIVE: To report a case of vancomycin-induced anaphylaxis (or anaphylactoid reaction) in a patient with a fever of unrecognized noninfectious origin. CASE…”
    Get full text
    Journal Article
  16. 16
  17. 17

    Nighttime sleep and daytime functioning (sleepiness and fatigue) in less well-defined chronic rheumatic diseases with particular reference to the ‘alpha-delta NREM sleep anomaly’ by Mahowald, Maren L., Mahowald, Mark W.

    Published in Sleep Medicine (01-07-2000)
    “…For the past 25 years, the ‘alpha-delta NREM sleep abnormality’ has been used by some as a defining or legitimizing marker for poorly defined rheumatic…”
    Get full text
    Book Review Journal Article
  18. 18
  19. 19
  20. 20

    Nighttime sleep and daytime functioning (sleepiness and fatigue) in well-defined chronic rheumatic diseases by Mahowald, Maren L., Mahowald, Mark W.

    Published in Sleep Medicine (01-07-2000)
    “…Wake/sleep complaints are very common in the rheumatic diseases, and include: insomnia, non-restorative sleep, frequent awakenings, daytime fatigue and…”
    Get full text
    Book Review Journal Article